Global Intellectual Property Center

GIPC Reports

U.S.-China IP Cooperation Dialogue 2015

U.S.-China IP Cooperation Dialogue 2015

This new report released by a joint United States-China working group outlines solutions to some of the most complex and challenging IP issues facing China. The report is the second released by the U.S.-China IP Cooperation Dialogue, a collaboration between the U.S. Chamber of Commerce and Renmin University’s China Intellectual Property Academy. The Dialogue brings together 10 thought leaders annually – five from the United States, five from China – committed to strengthening IP rights in China. The report examines five key areas: IP and innovation in the technical sector; IP and innovation in the pharmaceutical sector; judicial protection of IP; trade secrets protection; and copyright enforcement.

Unlimited Potential: Intellectual Property in the Trans-Pacific Partnership (TPP)

Unlimited Potential: Intellectual Property in the Trans-Pacific Partnership (TPP)

IP in TPPThe Global Intellectual Property Center’s International IP Index measures the intellectual property environment in 30 economies, including each of the Trans-Pacific Partnership (TPP) negotiating countries. The GIPC Index illustrates that the strength of intellectual property laws varies widely among TPP parties. Further, the index demonstrates direct linkages between a strong IP environment and the achievement of a number of highly desirable socio-economic goals; accordingly, an investment by the TPP parties in a strong, well-rounded intellectual property chapter would be likely to bring significant and direct benefits to each country.

Clinical Data and Disclosure Policies: The European Union, Member States, and International Best Practices

Clinical Data and Disclosure Policies: The European Union, Member States, and International Best Practices

EMA study cover graphicThe purpose of this report is twofold. First, provide an exhaustive analysis of the clinical data transparency aspects of EU Parliament Regulation 536/2014 on clinical trials and EMA’s finalized policies on Publication and Access to Clinical Trials Data. Second, review the wider policy implications and interface of these central EU-level policies with current data disclosure policies at the EU member state level, looking at five EU countries: Germany, Italy, Spain, Sweden, and the U.K.

UP: Unlimited Potential – GIPC Index Annex

UP: Unlimited Potential – GIPC Index Annex

This annex augments the analysis in the Global Intellectual Property Center International IP Index (GIPC Index) concerning the economic benefits of strengthening intellectual property (IP) protection, by comparing the GIPC Index scores with a number of additional variables using correlations (statistical measures of the likelihood of two elements occurring together). In doing so, the annex […]

UP: Unlimited Potential – The GIPC International IP Index, 3rd Edition

UP: Unlimited Potential – The GIPC International IP Index, 3rd Edition

Compressed-Cover-229x300At the Global Intellectual Property Center (GIPC), we believe that intellectual property (IP) is the key to promoting innovation and bringing new products to market. Progress on issues such as poverty, hunger, disease, and climate change requires the creative and innovative capacity of every global citizen. Now in its third edition, for 2015, the GIPC International IP Index (GIPC Index) provides a rigorous, data-based analysis that can help all economies put that critical human element to work.

Key Findings:

The GIPC Index highlights economies that have embraced strong IP protections as well as economies that would be well served to seek improvements to their IP regime. For the first time, the GIPC Index includes correlations on the ways that strong IP protections serve as a gateway to building innovative economies. Specifically, the GIPC Index identified a positive relationship between the following: